Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Foà

Showing results (21-30 of 527) with videos related to

Pageof 53
Sort By:
Blood|August 22, 2024
How I treat adult Ph+ ALLSabina Chiaretti, Robin Foà
American Journal of Hematology|December 21, 2022
The evolution of frontline therapy for adult Philadelphia-positive acute lymphoblastic leukemia: Giant strides and ongoing challengesAntoine N Saliba, Robin Foà
Reviews in Clinical and Experimental Hematology|July 26, 2006
New therapies in onco-hematology and new infectious risk factorsIlaria Del Giudice, Robin Foà
Blood|April 21, 2018
Gene mutations in lenalidomide-treated CLLFrancesca Romana Mauro, Robin Foà
The Lancet. Oncology|December 17, 2017
Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinibFrancesca R Mauro, Robin Foà
Haematologica|November 1, 2019
Response to Comment by Amato T. <i>et al.</i>Ilaria Del Giudice, Robin Foà
Reviews in Clinical and Experimental Hematology|August 1, 2006
Genomics in hematologic malignanciesRobin Foà, Victor A Hoffbrand
American Journal of Hematology|June 14, 2023
Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testingAntoine N Saliba, Robin Foà
Haematologica|February 2, 2019
Another step forward in the 20-year history of <i>IGHV</i> mutations in chronic lymphocytic leukemiaIlaria Del Giudice, Robin Foà
Leukemia|October 14, 2023
Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?Ilaria Del Giudice, Robin Foà
Pageof 53

Showing results (21-30 of 527) with videos related to

Sort By:
Pageof 53
Blood|August 22, 2024
How I treat adult Ph+ ALLSabina Chiaretti, Robin Foà
American Journal of Hematology|December 21, 2022
The evolution of frontline therapy for adult Philadelphia-positive acute lymphoblastic leukemia: Giant strides and ongoing challengesAntoine N Saliba, Robin Foà
Reviews in Clinical and Experimental Hematology|July 26, 2006
New therapies in onco-hematology and new infectious risk factorsIlaria Del Giudice, Robin Foà
Blood|April 21, 2018
Gene mutations in lenalidomide-treated CLLFrancesca Romana Mauro, Robin Foà
The Lancet. Oncology|December 17, 2017
Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinibFrancesca R Mauro, Robin Foà
Haematologica|November 1, 2019
Response to Comment by Amato T. <i>et al.</i>Ilaria Del Giudice, Robin Foà
Reviews in Clinical and Experimental Hematology|August 1, 2006
Genomics in hematologic malignanciesRobin Foà, Victor A Hoffbrand
American Journal of Hematology|June 14, 2023
Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testingAntoine N Saliba, Robin Foà
Haematologica|February 2, 2019
Another step forward in the 20-year history of <i>IGHV</i> mutations in chronic lymphocytic leukemiaIlaria Del Giudice, Robin Foà
Leukemia|October 14, 2023
Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?Ilaria Del Giudice, Robin Foà
Pageof 53